Uttam Kumar Nath
Overview
Explore the profile of Uttam Kumar Nath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bandyopadhyay A, Palepu S, Dhamija P, Nath U, Chetia R, Bakliwal A, et al.
BMJ Open
. 2023 Aug;
13(8):e066361.
PMID: 37643857
Objectives: The study aimed to compare early molecular response (EMR) rates at 3 months of imatinib therapy with and without vitamin D supplementation in patients newly diagnosed with chronic-phase chronic...
12.
Batra A, Vaniyath S, Kumar S, Melanda H, Kumari N, Hazarika N, et al.
Postgrad Med J
. 2023 Apr;
98(e1):e47-e48.
PMID: 37066582
No abstract available.
13.
Kunnumbrath A, Singh N, Gupta A, Chowdhury N, Nath U, Chandra H
J Lab Physicians
. 2022 Dec;
14(4):435-442.
PMID: 36531546
Chronic lymphocytic leukemia (CLL) is the commonest hematological malignancy in the West but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers. CD49d has...
14.
Sundriyal D, Nath U, Kumar P, Gupta S, Joseph D, Vaniyath S, et al.
South Asian J Cancer
. 2022 Dec;
11(2):156-159.
PMID: 36466983
Deepak Sundriyal The newly established medical oncology and hemato-oncology center at the All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India, provided us an opportunity to audit in-hospital mortalities...
15.
Vardhan G, Kumar V, Sahu P, Prakash A, Nath U, Handu S, et al.
Chirality
. 2022 Dec;
35(2):83-91.
PMID: 36458987
Lenalidomide (LND) is an analogue of thalidomide that is second generation immunomodulatory drugs (IMiDs). LND contains asymmetric carbon atom and exist R and S enantiomer. S (-) form of enantiomer...
16.
Yadav R, Nath U, Celik I, Handu S, Jain N, Dhamija P
Biomed Pharmacother
. 2022 Nov;
157:113963.
PMID: 36399828
The proteasome subunit β5 (PSMβ5) is a chief target of proteasome inhibitors (PIs) for treatment of multiple myeloma (MM). The relevance of PSMβ5 mutations and their functional impact on the...
17.
Vathulya M, Chattopadhyay D, Kandwal P, Nath U, Kapoor A, Sinha M
Adv Wound Care (New Rochelle)
. 2022 Oct;
12(9):513-528.
PMID: 36301930
Pressure ulcers are very difficult to treat and pose an economic burden, just below cancer and cardiovascular illness, at 4.82 billion U.S. dollars. It is important to understand the pathophysiology...
18.
Mamgain G, Naithani M, Patra P, Mamgain M, Morang S, Nayak J, et al.
Cureus
. 2022 Sep;
14(8):e28241.
PMID: 36158348
Introduction: Next-generation sequencing (NGS) elucidates the diffuse large B-cell lymphoma (DLBCL) genetic characteristics by finding recurrent and novel somatic mutations. This observational study attempted to create an NGS panel with...
19.
Mamgain G, Patra P, Naithani M, Nath U
Cureus
. 2021 Dec;
13(10):e19047.
PMID: 34853760
Human body harbours enormous numbers of microbial organisms, including bacteria, viruses, and fungi which have a momentous role in well-being and illness in humans. Immune system shelters us from pathogenic...
20.
De D, Nath U, Chakrabarti P
J Assoc Physicians India
. 2021 Nov;
69(11):11-12.
PMID: 34781613
Hb E-β thalassemia is the most common form of hemoglobinopathy in Southeast Asia and eastern India. Iron overload resulting from blood transfusion and increased intestinal iron absorption promotes the formation...